Article Data

  • Views 2481
  • Dowloads 246

Original Research

Open Access

Abnormal ST segment in electrocardiograph predicts poor outcome in patients with acute subarachnoid hemorrhage

  • Yan Xu1,†
  • Yong Zhang2,†
  • Biaohu Liu3
  • Wen Xing2
  • Deguo Wang2

1Department of Education and Research, First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), 241001 Wuhu, China

2Department of Gerontology, First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), 241001 Wuhu, China

3Department of Medical Imaging, First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), 241001 Wuhu, China

DOI: 10.22514/sv.2021.065 Vol.17,Issue 6,November 2021 pp.52-58

Submitted: 31 January 2021 Accepted: 02 March 2021

Published: 08 November 2021

*Corresponding Author(s): Biaohu Liu E-mail: lbhwuhu@163.com
*Corresponding Author(s): Deguo Wang E-mail: wangdeguo@wnmc.edu.cn

† These authors contributed equally.

Abstract

Background and purpose: There are high occurrences of abnormal electrocardio-graphic (ECG) in patients with acute subarachnoid hemorrhage (SAH). Thus, we want to determine whether any specific characteristics in ECG are associated with poor clinical outcomes in patients with SAH inhospital.

Methods: A total of 145 patient who selected from 270 cases with non-traumatic SAH was included in this study. A standard surface ECG was assessed for all patients within 72 hours of SAH onset. All patients were stratified into Good or Poor outcome groups according to the in-hospital mortality or neurological worsening (World Federation of Neurological Surgeons, WFNS class) when they discharge from our hospital.

Results: These patients in Poor outcome (n = 29) had significantly high heart rate (93.52± 22.23 bpm vs 78.42 ± 18 bpm, P < 0.01), prolonged QTc (458.17 ± 44.88 ms vs 436.89 ± 43.46 ms, P = 0.027) and corrected Tpeak–Tend interval (cTp-e, 106.19 ± 22.22 ms vs 93.14 ± 21.04 ms, P = 0.007) and high occurrence of ECG abnormalities including ST segment (90% vs 44%, P < 0.01) and left ventricular high voltage (28%vs 10%, P = 0.03). Multivariable logistic regression identified independent variables indicating poor outcome in-hospital including abnormal ST (OR = 2.507, 95% CI, 1.051-5.941, P = 0.037) and WFNS class (OR = 2.280, 95% CI, 1.605-3.240, P < 0.001).

Conclusions: Abnormal ST segment of ECG is an independent indicator for poor inhospital outcomes regardless the severity of patients with SAH and warrant to further study their mechanism in the future.


Keywords

Subarachnoid hemorrhage; In-hospital prognosis; Electrocardiographic abnormalities; ST elevation and depression; QTc interval


Cite and Share

Yan Xu,Yong Zhang,Biaohu Liu,Wen Xing,Deguo Wang. Abnormal ST segment in electrocardiograph predicts poor outcome in patients with acute subarachnoid hemorrhage. Signa Vitae. 2021. 17(6);52-58.

References

[1] Andreoli A, di Pasquale G, Pinelli G, Grazi P, Tognetti F, Testa C. Subarachnoid hemorrhage: frequency and severity of cardiac arrhythmias. A survey of 70 cases studied in the acute phase. Stroke. 1987; 18: 558–564.

[2] Sakr YL, Lim N, Amaral ACKB, Ghosn I, Carvalho FB, Renard M, et al. Relation of ECG changes to neurological outcome in patients with aneurysmal subarachnoid hemorrhage. International Journal of Cardiology. 2004; 96: 369–373.

[3] Jung J, Min P, Rim S, Ha J, Chung N, Lee K. Are Electrocardiographic changes in patients with acute subarachnoid hemorrhage associated with takotsubo cardiomyopathy? Cardiology. 2010; 115: 98–106.

[4] Micieli G, Cavallini A. The autonomic nervous system and ischemic stroke: a reciprocal interdependence. Clinical Autonomic Research. 2008; 18: 308–317.

[5] Samuels MA. The brain-heart connection. Circulation. 2007; 116: 77–84.

[6] Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circulation Research. 2014; 114: 1004–1021.

[7] Franciosi S, Perry FKG, Roston TM, Armstrong KR, Claydon VE, Sanatani S. The role of the autonomic nervous system in arrhythmias and sudden cardiac death. Autonomic Neuroscience. 2017; 205: 1–11.

[8] Katsanos AH, Korantzopoulos P, Tsivgoulis G, Kyritsis AP, Kosmidou M, Giannopoulos S. Electrocardiographic abnormalities and cardiac ar-rhythmias in structural brain lesions. International Journal of Cardiology. 2013; 167: 328–334.

[9] Lai C, Juan Y, Chang S, Lee W, How C, Hsu T. Subarachnoid haemorrhage mimicking transient ST-segment elevation myocardial infarction. Acta Clinica Belgica. 2015; 70: 304–306.

[10] Heo WJ, Kang JH, Jeong WS, Jeong MY, Lee SH, Seo JY, et al. Subarachnoid hemorrhage misdiagnosed as an acute ST elevation myocardial infarction. Korean Circulation Journal. 2012; 42: 216–219.

[11] Christensen H, Fogh Christensen A, Boysen G. Abnormalities on ECG and telemetry predict stroke outcome at 3 months. Journal of the Neurological Sciences. 2005; 234: 99–103.

[12] Bobinger T, Kallmünzer B, Kopp M, Kurka N, Arnold M, Hilz M, et al. Prevalence and impact on outcome of electrocardiographic early repolarization patterns among stroke patients: a prospective observational study. Clinical Research in Cardiology. 2015; 104: 666–671.

[13] Ibrahim GM, Macdonald RL. Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2012; 43: 2102–2107.

[14] Zaroff JG, Rordorf GA, Newell JB, Ogilvy CS, Levinson JR. Cardiac out-come in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery. 1999; 44: 34–39.

[15] Norberg E, Odenstedt-Herges H, Rydenhag B, Oras J. Impact of acute cardiac complications after subarachnoid hemorrhage on long-term mortality and cardiovascular events. Neurocritical Care. 2018; 29: 404–412.

[16] Dong Y, Guo Z, Li Q, Ni W, Gu H, Gu Y, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage. Stroke and Vascular Neurology. 2019; 4: 176–181.

[17] Meurer WJ, Walsh B, Vilke GM, Coyne CJ. Clinical guidelines for the emergency department evaluation of subarachnoid hemorrhage. The Journal of Emergency Medicine. 2016; 50: 696–701.

[18] Huang C, Huang C, Kuo H, Chan C, Chen J, Chen W. The 12-lead electrocardiogram in patients with subarachnoid hemorrhage: early risk prognostication. The American Journal of Emergency Medicine. 2012; 30: 732–736.

[19] Hong L, Andersen LJ, Graff C, Vedel-Larsen E, Wang F, Struijk JJ, et al. T-wave morphology analysis of competitive athletes. Journal of Electrocardiology. 2015; 48: 35–42.

[20] Sugimoto K, Yamada A, Inamasu J, Hirose Y, Takada K, Sugimoto K, et al. Electrocadiographic scoring helps predict left ventricular wall motion abnormality commonly observed after subarachnoid hemorrhage. Journal of Stroke and Cerebrovascular Diseases. 2018; 27: 3148–3154.

[21] Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the international society for computerized electrocardiology. Journal of the American College of Cardiology. 2009; 53: 982–991.

[22] Castro Hevia J, Antzelevitch C, Tornés Bárzaga F, Dorantes Sánchez M, Dorticós Balea F, Zayas Molina R, et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. Journal of the American College of Cardiology. 2006; 47: 1828–1834.

[23] Bachmann TN, Skov MW, Rasmussen PV, Graff C, Pietersen A, Lind B, et al. Electrocardiographic Tpeak-Tend interval and risk of cardiovascular morbidity and mortality: results from the Copenhagen ECG study. Heart Rhythm. 2016; 13: 915–924.

[24] Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and in-terpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. Journal of the American College of Cardiology. 2009; 53: 992–1002.

[25] Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for computerized electrocardiology. Circulation. 2009; 119: e251–e261.

[26] Junttila E, Vaara M, Koskenkari J, Ohtonen P, Karttunen A, Raatikainen P, et al. Repolarization abnormalities in patients with subarachnoid and intracerebral hemorrhage: predisposing factors and association with outcome. Anesthesia and Analgesia. 2013; 116: 190–197.

[27] Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation. 2009; 119: e241–e250.

[28] Wagner GS, Macfarlane P, Wellens H, Josephson M, Gorgels A, Mirvis DM, et al. AHA/ACCF/HRS recommendations for the stan-dardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation. 2009; 119: e262–e270.

[29]

Sandhu R, Aronow WS, Rajdev A, Sukhija R, Amin H, D’aquila K, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. The American Journal of Cardiology. 2008; 102: 632–634.

[30] Xu M, Lin J, Wang D, Liu M, Hao Z, Lei C. Cardiac troponin and cerebral herniation in acute intracerebral hemorrhage. Brain and Behavior. 2017; 7: e00697.

[31] van Bree MDR, Roos YBWEM, van der Bilt IAC, Wilde AAM, Sprengers MES, de Gans K, et al. Prevalence and characterization of ECG abnormalities after intracerebral hemorrhage. Neurocritical Care. 2010; 12: 50–55.

[32] Zhang L, Qi S. Electrocardiographic abnormalities predict adverse clinical outcomes in patients with subarachnoid hemorrhage. Journal of Stroke and Cerebrovascular Diseases. 2016; 25: 2653–2659.

[33] Hravnak M, Frangiskakis JM, Crago EA, Chang Y, Tanabe M, Gorcsan J, et al. Elevated cardiac troponin I and relationship to persistence of elec-trocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. Stroke. 2009; 40: 3478–3484.

[34] Ichinomiya T, Terao Y, Miura K, Higashijima U, Tanise T, Fukusaki M, et al. QTc interval and neurological outcomes in aneurysmal subarachnoid hemorrhage. Neurocritical Care. 2010; 13: 347–354.

[35] Coghlan LA, Hindman BJ, Bayman EO, Banki NM, Gelb AW, Todd MM, et al. Independent associations between electrocardiographic abnormalities and outcomes in patients with aneurysmal subarachnoid hemorrhage: findings from the intraoperative hypothermia aneurysm surgery trial. Stroke. 2009; 40: 412–418.

[36] Okada J, Washio T, Maehara A, Momomura S, Sugiura S, Hisada T. Transmural and apicobasal gradients in repolarization contribute to T-wave genesis in human surface ECG. American Journal of Physiology Heart and Circulatory Physiology. 2011; 301: H200–H208.

[37] Elsharkawy H, Abd-Elsayed A, El-Hadi S, Provencio J, Tetzlaff J. Fluctuating electrocardiographic changes predict poor outcomes after acute subarachnoid hemorrhage. The Ochsner Journal. 2016; 16: 225–229.

[38] Jangra K, Grover VK, Bhagat H, Bhardwaj A, Tewari MK, Kumar B, et al. Evaluation of the effect of aneurysmal clipping on electrocardio-graphy and echocardiographic changes in patients with subarachnoid hemorrhage: a prospective observational study. Journal of Neurosurgical Anesthesiology. 2017; 29: 335–340.

[39] Tse G, Gong M, Wong WT, Georgopoulos S, Letsas KP, Vassiliou VS, et al. The Tpeak-Tend interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: a systematic review and meta-analysis. Heart Rhythm. 2017; 14: 1131–1137.

[40] Komatsuzaki M, Takasusuki T, Kimura Y, Yamaguchi S. Assessment of the ECG T-wave in patients with subarachnoid hemorrhage. Journal of Neurosurgical Anesthesiology. 2021; 33: 58–64.

[41] Crompton MR. Hypothalamic lesions following the rupture of cerebral berry aneurysms. Brain. 1963; 86: 301–314.

[42] Sugimoto K, Inamasu J, Kato Y, Yamada Y, Ganaha T, Oheda M, et al. Association between elevated plasma norepinephrine levels and cardiac wall motion abnormality in poor-grade subarachnoid hemorrhage patients. Neurosurgical Review. 2013; 36: 259–266.

[43] Yuki K, Kodama Y, Onda J, Emoto K, Morimoto T, Uozumi T. Coronary vasospasm following subarachnoid hemorrhage as a cause of stunned myocardium. Case report. Journal of Neurosurgery. 1991; 75: 308–311.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top